DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Geron Corporation (GERN)
« Back to company indexGERN Chatter Timeline
Stock Ticker for GERN
Most Active Tweeters for GERN
| User | Tweets |
|---|---|
| @gcassidy718 | 6 |
| @newsfilterio | 3 |
| @VisualStockRSRC | 3 |
| @Brandon555577 | 3 |
| @BlueBioNow | 2 |
Recent Tweets for GERN
 |
@gcassidy718 $GERN what a Company -4.03 % change recently https://t.co/REKjzFhD5H October 20th 2019, 10:10pm |
|
@gcassidy718 $GERN Hoping to exit this position at some point . . . -4.03 % change recently https://t.co/REKjzFhD5H October 19th 2019, 7:10pm |
 |
@TickerSentiment Sentiment for $GERN out of 4 total scores; 75 % is positive and 25 % is negative. #sentiment https://t.co/N3GL3kzq31 October 18th 2019, 7:10pm |
 |
@SwingTradeBot 200 DMA Support today: $GERN $HIIQ ... https://t.co/LjP7KUcNnp October 18th 2019, 10:10am |
 |
@newsfilterio Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) $GERN https://t.co/vPgze4IWg8 October 17th 2019, 4:10pm |
 |
@Brandon555577 $GERN - Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/CZvGlDJbDL October 17th 2019, 4:10pm |
 |
@VisualStockRSRC $GERN - Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/15DijmxMW9 October 17th 2019, 4:10pm |
 |
@FlashAlert_me $GERN: Press Release published article on October 17, 16:10:00: Geron Reports Inducement Grants Under Nasdaq Listin… https://t.co/qFqHZ2oeng October 17th 2019, 4:10pm |
 |
@BlueBioNow $GERN price movement 2.40 % https://t.co/MFBtbC8TfM October 16th 2019, 3:10am |
 |
@1035l @BlackBoxGuru After getting dropped by JNJ I thought $gern was done ? October 15th 2019, 8:10am |
 |
@Stock_News_Now $GERN: New SEC Filing for GERN: Form 8-K (No. 0001206774-19-003542): https://t.co/x17EyXunyz October 15th 2019, 7:10am |
 |
@fintel_io $GERN / Geron files form 8-K - Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creat… https://t.co/pJRF1rmtC5 October 15th 2019, 7:10am |
|
@Brandon555577 $GERN - Current Report Filing (8-k) https://t.co/59PtHWB5mL October 15th 2019, 7:10am |
|
@VisualStockRSRC $GERN - Current Report Filing (8-k) https://t.co/RnhQGUHnOD October 15th 2019, 7:10am |
 |
@confcalltran Entry into a Material https://t.co/euMP17AGBe $GERN October 15th 2019, 7:10am |
|
@FlashAlert_me $GERN filed form 8-K on October 15, 06:55:10: Item1.01: Entry into a Material Definitive Agreement https://t.co/UPSrFA4fwa October 15th 2019, 6:10am |
 |
@BlackBoxGuru $GERN everyone and their mother knew Geron was taking this into phase 3. What was the big surprise? October 14th 2019, 5:10pm |
|
@gcassidy718 $GERN price movement 6.25 % https://t.co/REKjzFhD5H October 13th 2019, 1:10pm |
 |
@TickerReport Geron $GERN Trading 6.3% Higher https://t.co/vHDFZpe5YK October 13th 2019, 10:10am |
 |
@dailypoliticaln Geron $GERN Stock Price Up 6.3% https://t.co/gRt1gkosn1 October 13th 2019, 10:10am |
 |
@ZolmaxNews Geron $GERN Trading 6.3% Higher https://t.co/yKl0ekSA6S October 13th 2019, 10:10am |
 |
@jerchess $GERN Dr. J is growing more bullish https://t.co/bMphNFNlSq October 12th 2019, 6:10pm |
|
@gcassidy718 $GERN auction is now open. 6.25 % change recently https://t.co/REKjzFhD5H October 12th 2019, 1:10pm |
 |
@bbnsnews Geron Co. $GERN Given Consensus Recommendation of “Buy” by Analysts https://t.co/N9wIwlVhrz October 12th 2019, 12:10pm |
|
@BlueBioNow $GERN significant price movement on this stock 2.43 % change recently https://t.co/MFBtbC8TfM October 12th 2019, 8:10am |
 |
@macondailynews Geron $GERN Stock Price Up 6.3% https://t.co/MnJDdlxov5 October 11th 2019, 9:10pm |
 |
@MaisaCorp $GERN has dosed the first patient in a phase III trial of its imetelstat drug candidate as a potential alternative… https://t.co/AWSEosfXHJ October 11th 2019, 4:10pm |
 |
@1000Shares RT @ez_alertz: $GERN Geron Starts Enrollment in Phase III MDS Study on Imetelstat https://t.co/A7ZXjzhekQ October 11th 2019, 12:10pm |
 |
@Traderideas1 Now this sucker $GERN decided to move when I got out yesterday. October 11th 2019, 12:10pm |
 |
@COCKRELLGROUP $GERN Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes https://t.co/UMNU6cwtmn October 11th 2019, 10:10am |
|
@COCKRELLGROUP $GERN announced start of enrollment in phase III MDS study, evaluating its sole pipeline candidate, imetelstat, for… https://t.co/u9qZUyCHNo October 11th 2019, 10:10am |
 |
@ez_alertz $GERN Geron Starts Enrollment in Phase III MDS Study on Imetelstat https://t.co/A7ZXjzhekQ October 11th 2019, 10:10am |
 |
@1stOncology Geron Announces First Patient Dosed in #IMerge Phase 3 Clinical Trial in Lower Risk #MyelodysplasticSyndromes $GERN https://t.co/vxDcgPaD6k October 11th 2019, 10:10am |
 |
@OpenOutcrier $GERN (+1.4% pre) Geron launches late-stage IMerge trial in lower risk MDS - SA https://t.co/IEBlYInRHv October 11th 2019, 8:10am |
 |
@WallStCards $GERN Geron launches late-stage IMerge trial in lower risk MDS October 11th 2019, 8:10am |
|
@newsfilterio Geron launches late-stage IMerge trial in lower risk MDS $GERN https://t.co/StG0UXA8kM October 11th 2019, 6:10am |
 |
@MarketCurrents $GERN - Geron launches late-stage IMerge trial in lower risk MDS https://t.co/FrS133lVxq October 11th 2019, 6:10am |
 |
@newswithvalue $GERN: Geron Announces First Patient Dosed in IMerge Phase 3 Clinical …: https://t.co/RJshTubok5 October 10th 2019, 6:10pm |
 |
@TopStockAlerts1 $GERN moving on news October 10th 2019, 5:10pm |
|
@newsfilterio Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes $GERN https://t.co/2VA3yBMVyR October 10th 2019, 5:10pm |
 |
@StockAuthority $GERN Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes October 10th 2019, 5:10pm |
|
@Brandon555577 $GERN - Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic https://t.co/f86DG6jO5N October 10th 2019, 5:10pm |
|
@VisualStockRSRC $GERN - Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic https://t.co/cy2jzXTL3J October 10th 2019, 5:10pm |
|
@gcassidy718 $GERN Would say I'm surprised, but I'm not. Will check ER. Might dabble again. Maybe. 2.48 % change recently https://t.co/REKjzFhD5H October 10th 2019, 2:10pm |
|
@gcassidy718 $GERN Looking for any entry here......... ;) 2.13 % change recently https://t.co/REKjzFhD5H October 9th 2019, 3:10pm |
 |
@TekATL3 $GERN watch this continue developing. Measured move to 2.25. Close above 1.80/.75 triggers a larger pattern https://t.co/EsgoiSmkXZ October 9th 2019, 1:10am |
 |
@IRAMarketReport Analysts Set Geron Co. $GERN PT at $3.90 https://t.co/NPSX9k57fm #markets October 8th 2019, 11:10pm |
 |
@chaffeybreeze Analysts Set Geron Co. $GERN PT at $3.90 https://t.co/P08nmtPBFf #stocks October 8th 2019, 11:10pm |
|
@COCKRELLGROUP Geron $GERN eInvestor Presentation - Slideshow https://t.co/nfgWypYwYn October 7th 2019, 10:10am |
 |
@OlympiaReport Geron Co. $GERN Expected to Announce Quarterly Sales of $140,000.00 https://t.co/bAvOSN0p3f October 5th 2019, 2:10am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.